Evaluation of the Validity of the Prothrombin Time Internation Normalised Ratio (PT/INR) Measured at the point-of Care on the Arterial Bloodline of Haemodialysis Extracorporeal Blood Flow

University Hospital, Brest30 enrolled

Overview

The purpose of this study is to evaluate the INR value of hemodialyzed patient coagulation state (prothrombin time) measured inside the therapeutical zone and thanks to a portable monitor. The values obtained at the point of care will be compared to the standard biological assessment.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Haemodialysis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age \> 18 * Haemodialyzed patient whose INR needs to be monitored * Patient not objecting to participate in the study

Locations (1)

CHU Brest

Brest, France

RECRUITING

Outcomes

Primary Outcomes

correlation ratio between point-of-care PT/INR value and standard laboratory assessement

Time frame: 5 months

Central Contacts

Yannick Le meur, MD-PhD

CONTACT

yannick.lemeur@chu-brest.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.